Page last updated: 2024-11-08

glucopyranosylamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

glucopyranosylamine: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID193433
CHEMBL ID2272078
SCHEMBL ID1593477
MeSH IDM0204149

Synonyms (20)

Synonym
7284-37-9
(2r,3r,4s,5s,6r)-2-amino-6-(hydroxymethyl)oxane-3,4,5-triol
AKOS006272408
1-amino-1-deoxy- -d-glucose
(2r,3r,5s,6r)-2-amino-6-hydroxymethyl-tetrahydro-pyran-3,4,5-triol
glucopyranosylamine
beta-d-glucopyranosylamine
b-d-glucopyranosyl amine
CHEMBL2272078
SCHEMBL1593477
(2r,3r,4s,5s,6r)-2-amino-6-(hydroxymethyl)tetrahydro-2h-pyran-3,4,5-triol
DTXSID20223153
1-amino-1-deoxy-beta-d-glucopyranose
beta-d-glucosylamine
WCWOEQFAYSXBRK-VFUOTHLCSA-N
W-203656
mfcd00069837
GS-6152
H10504
A866195
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID1105001Antifungal activity against Trametes versicolor Quel. CTB 863-A assessed as mycelial growth inhibition at 1 x 10'-4 mol/ml after 9 days relative to control2011Pest management science, Mar, Volume: 67, Issue:3
Synthesis of D-glucosamine quaternary ammonium derivatives and evaluation of their antifungal activity together with aminodeoxyglucose derivatives against two wood fungi Coriolus versicolor and Poria placenta: structure-activity relationships.
AID1104998Antifungal activity against Poria placenta FPRL 280 assessed as mycelial growth inhibition at 0.75 x 10'-4 mol/ml after 9 days relative to control2011Pest management science, Mar, Volume: 67, Issue:3
Synthesis of D-glucosamine quaternary ammonium derivatives and evaluation of their antifungal activity together with aminodeoxyglucose derivatives against two wood fungi Coriolus versicolor and Poria placenta: structure-activity relationships.
AID1104999Antifungal activity against Poria placenta FPRL 280 assessed as mycelial growth inhibition at 0.5 x 10'-4 mol/ml after 9 days relative to control2011Pest management science, Mar, Volume: 67, Issue:3
Synthesis of D-glucosamine quaternary ammonium derivatives and evaluation of their antifungal activity together with aminodeoxyglucose derivatives against two wood fungi Coriolus versicolor and Poria placenta: structure-activity relationships.
AID1105000Antifungal activity against Trametes versicolor Quel. CTB 863-A assessed as mycelial growth inhibition at 1.5 x 10'-4 mol/ml after 9 days relative to control2011Pest management science, Mar, Volume: 67, Issue:3
Synthesis of D-glucosamine quaternary ammonium derivatives and evaluation of their antifungal activity together with aminodeoxyglucose derivatives against two wood fungi Coriolus versicolor and Poria placenta: structure-activity relationships.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (7.69)18.2507
2000's9 (69.23)29.6817
2010's3 (23.08)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.71

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.71 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index5.35 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.71)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]